News

Viking Therapeutics Set to Showcase Innovations at Investor Events

Viking Therapeutics Set to Showcase Innovations at Investor Events

Viking Therapeutics Set to Showcase Innovations at Investor Events

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for metabolic and endocrine disorders, has exciting news regarding its participation in several upcoming investor conferences. These gatherings are excellent opportunities for Viking to highlight its advancements and connect with potential investors.

Investor Conference Details

The company’s participation includes several high-profile conferences designed to foster dialogue with the investment community. Here are the key details:

Truist Healthcare Conference

Details: Management will engage in a fireside chat and conduct one-on-one meetings.

Conference Date: Scheduled for November 7, 2024.

Fireside Chat Timing: 12:30 – 1:00 p.m. Eastern on Thursday.

Location: New York.

UBS Global Healthcare Conference

Details: Management will engage in one-on-one meetings.

Conference Dates: Set for November 11-14, 2024.

Location: Rancho Palos Verdes.

Stifel 2024 Healthcare Conference

Details: Management will present the company’s latest developments and participate in one-on-one meetings.

Conference Dates: November 18-19, 2024.

Presentation Timing: 8:35 – 9:05 a.m. Eastern on November 19.

Location: New York.

Jefferies London Healthcare Conference 2024

Details: Viking management will present the company’s initiatives and hold one-on-one meetings.

Conference Dates: November 19-21, 2024.

Presentation Timing: 9:00 – 9:25 a.m. GMT on November 21.

Location: London.

What to Expect from the Presentations

During these conferences, Viking Therapeutics aims to provide insights into its promising pipeline of therapies targeting various metabolic and endocrine disorders. One standout candidate is VK2735, a dual agonist for GLP-1 and GIP receptors. Current trials have shown it to be safe and effective, paving the way for potential market introduction.

The company is also progressing with VK2809, a selective thyroid hormone receptor beta agonist aimed at treating conditions like NASH and NAFLD. This drug has demonstrated significant efficacy in trials, indicating a bright future for its market presence.

About Viking Therapeutics, Inc.

Viking Therapeutics, Inc. specializes in developing first-in-class and best-in-class therapies focused on metabolic and endocrine health. It currently has three compounds undergoing clinical trials, leveraging its extensive expertise in metabolism to innovate and improve patient outcomes. Each clinical program is backed by solid research, showcasing the company's commitment to advancing treatment options.

Frequently Asked Questions

What type of company is Viking Therapeutics?

Viking Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for metabolic and endocrine disorders.

Which major investor conferences will Viking attend?

Viking will participate in the Truist Healthcare Conference, UBS Global Healthcare Conference, Stifel 2024 Healthcare Conference, and Jefferies London Healthcare Conference.

What therapies is Viking currently developing?

Viking is developing several innovative therapies including VK2735 for metabolic disorders and VK2809 for lipid and metabolic disorders.

When will the conferences take place?

The upcoming conferences are scheduled from November 7 to November 21, 2024.

How can I find more information about Viking Therapeutics?

For detailed insights on Viking Therapeutics and their ongoing projects, please visit their official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading

Top 5 Most Recently Viewed Articles

Aker Carbon Capture's Major Share Transfer: What It Means

Updated Category News Views 171

Aker Carbon Capture's Major Share Transfer Explained Aker Carbon Capture ASA is undergoing a significant transformation that could impact its future operations and market position. Recently, the company experienced an internal reorganization in the wake of a merger involving Aker Horizons Holding AS and AKH HoldCo AS, a subsidiary of Aker ASA. As part of this transition,...

Continue Reading
Understanding Your Rights: Steps After an Arrest Explained

Updated Category News Views 220

What to Do Right After an Arrest When someone finds themselves facing an arrest, the emotional turmoil can be overwhelming. In such critical moments, knowing how to navigate the complexities of the legal system can make a significant difference. This article provides practical advice on what actions to take following an arrest, emphasizing the importance of handling the...

Continue Reading
Dynamic Funds Enhances Investment Portfolios with Strategic Changes

Updated Category News Views 173

Strategic Enhancements to Dynamic Funds' Investment Offerings Dynamic Funds, managed by 1832 Asset Management L.P., has announced significant enhancements to its investment solutions aimed at providing clients with superior financial products. Following various mergers within the investment lineup, effective adjustments, including name changes and fee reductions, are set...

Continue Reading
Critical Insights on KinderCare's Securities Fraud Allegations

Updated Category News Views 160

Understanding the KinderCare Class Action Lawsuit Pomerantz LLP has announced a significant class action lawsuit against KinderCare Learning Companies, Inc. (KLC), a firm specializing in early childhood education. This legal action is designed to involve those investors who may have suffered financial losses during their time with the company. If you are one of these...

Continue Reading
Exciting Drill Results from Globex Mining's Nordeau West Claims

Updated Category News Views 159

Recent Drilling Highlights on Nordeau West Royalty Claims Globex Mining Enterprises Inc. is thrilled to share the latest update concerning drilling outcomes from Cartier Resources Inc. conducted on the Nordeau West claims. These claims are situated just east of the renowned Chimo Gold Mine and have yielded promising new assay results. Drilling Results Breakdown The...

Continue Reading